Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Acupressure (GB30) on Ventrogluteal Intramuscular Injection Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03553901
Recruitment Status : Completed
First Posted : June 12, 2018
Last Update Posted : June 13, 2018
Sponsor:
Information provided by (Responsible Party):
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Brief Summary:
Acupressure is an ancient manual therapy which fingers are used to press key points on the body. These points are the same with acupuncture points but in contrast to acupuncture, acupressure uses gentle but firm pressure with fingers and hands. The purpose of this study is to investigate effect of acupressure onto GB30 poin for ventrogluteal intramuscular injection pain.The study was designed as a prospective, single-blind, crossover study. The study included 72 volunteer students attending Faculty of Health Sciences, Nursing Department.

Condition or disease Intervention/treatment Phase
Acute Pain Injection Needle Phobia Procedure: Acupressure Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: The Effect of Acupressure (GB30) on Ventrogluteal Intramuscular Injection Pain - A Crossover Randomized Single-blind Study
Actual Study Start Date : September 1, 2016
Actual Primary Completion Date : June 1, 2017
Actual Study Completion Date : August 1, 2017

Arm Intervention/treatment
Experimental: Acupressure
Acupressure is applied before injection
Procedure: Acupressure
Acupressure was performed before the injection onto GB30 point

No Intervention: Control group
acupressure is not applied before injection



Primary Outcome Measures :
  1. Assessment of pain during intramuscular injection with 10 cm VAS (Visual Analog Scale) [ Time Frame: 2 minutes ]
    Assessment of pain during intramuscular injection will be marked on 10 cm VAS scale 0-10 ( 0:no pain 10:Worst possible pain ) by the patient and will be measured



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Body Mass Index (BMI) of 18.5 to 29.9kg/m2
  • Voluntariness

Exclusion Criteria:

  • history of IM injection within 2 weeks

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03553901


Sponsors and Collaborators
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Investigators
Layout table for investigator information
Study Director: Gökhan inangil Sultan Abdulhamid Han

Publications:
Layout table for additonal information
Responsible Party: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
ClinicalTrials.gov Identifier: NCT03553901     History of Changes
Other Study ID Numbers: Sultan Abdulhamid
First Posted: June 12, 2018    Key Record Dates
Last Update Posted: June 13, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Pain
Pain
Neurologic Manifestations
Signs and Symptoms